Integrative analysis of transcriptomic and clinical data uncovers the tumor suppressive activity of MITF in prostate cancer.
L. Valcarcel, A. Macchia, N. Martin, A. R. Cortazar, A. Schaub, M. Pujana, S. Fernandez, I. Lacasa, A. Santos, A. Loizaga, M. Unda, I. Hermanova, I. Astobiza, M. Graupera, J. Starkova, , V. Torrano
The paper identifies MITF as a tumor suppressor in prostate cancer and reveals CRYAB as a direct target mediating its suppressive activity through integrative transcriptomic and clinical analysis.
bioRxiv · Aug 14, 2018Cancer Biology